MEDLIVE TECHNOLOGY CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.21 HKD | -0.73% |
|
+12.16% | -3.18% |
| Sales 2023 | 412M 56.92M 446M | Sales 2024 * | 517M 71.39M 559M | Capitalization | 5.56B 769M 6.02B |
|---|---|---|---|---|---|
| Net income 2023 | 242M 33.43M 262M | Net income 2024 * | 240M 33.15M 260M | EV / Sales 2023 | 13.6 x |
| Net cash position 2023 * | 4.39B 606M 4.75B | Net cash position 2024 * | 4.34B 600M 4.7B | EV / Sales 2024 * | 2.36 x |
| P/E ratio 2023 |
23.4
x | P/E ratio 2024 * |
27
x | Employees | 742 |
| Yield 2023 * |
1.41% | Yield 2024 * |
1.87% | Free-Float | 25.35% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.73% | ||
| 1 week | +12.36% | ||
| Current month | +9.54% | ||
| 1 month | +10.56% | ||
| 3 months | +27.23% | ||
| 6 months | +10.27% | ||
| Current year | -2.48% |
1 week
7.18
8.35
1 month
7.098.58
Current year
5.858.58
1 year
5.599.90
3 years
5.5947.00
5 years
5.5947.00
10 years
5.5947.00
| Managers | Title | Age | Since |
|---|---|---|---|
Li Ping Tian
CEO | Chief Executive Officer | 57 | 13-04-07 |
Li Xin Tian
FOU | Founder | 55 | 13-04-07 |
Jiang Nan
CTO | Chief Tech/Sci/R&D Officer | 36 | 13-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Richard Yeh
BRD | Director/Board Member | 56 | 21-07-13 |
Eiji Tsuchiya
BRD | Director/Board Member | 59 | 13-11-30 |
Li Xin Tian
FOU | Founder | 55 | 13-04-07 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 8.21 | -0.73% | 29 500 |
| 24-04-25 | 8.27 | +0.73% | 425,500 |
| 24-04-24 | 8.21 | +4.32% | 730,500 |
| 24-04-23 | 7.87 | +5.64% | 271,500 |
| 24-04-22 | 7.45 | +1.78% | 227,000 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 04:09 am EDT
More quotes
Medlive Technology Co Ltd is a China-based investment holding company mainly operates online professional physician platform. The Company mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The Company mainly conducts its business within domestic market.
Sector
Advertising & Marketing
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.654
CNY
Average target price
9.314
CNY
Spread / Average Target
+21.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.48% | 762M | |
| +22.14% | 28.07B | |
| +11.79% | 18.8B | |
| +10.60% | 13.95B | |
| -4.53% | 11.85B | |
| +5.76% | 10.72B | |
| +6.87% | 4.43B | |
| -12.83% | 3.8B | |
| +33.23% | 3.47B | |
| +10.33% | 3.38B |
- Stock Market
- Equities
- 2192 Stock
